In fact, disruption of intestinal homeostasis and associated gut microbiome dysbiosis promote T2DM [28], and intensive insulin therapy and oral hypoglycemic agents recover gut microbiome dysbiosis [28,29,30]. This evidence concerns the gene INS and type 2 diabetes mellitus.